BridgeBio Pharma Inc (NASDAQ:BBIO)

26.34
Delayed Data
As of 4:00pm ET
 -0.79 / -2.91%
Today’s Change
6.64
Today|||52-Week Range
36.36
+245.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2017

2018

--

--
AssetsCash92.0M436.1M----
 
 
 
Short Term Investment Cash72.0M343.9M----
 
 
 
Cash & Short Term Investments92.0M436.1M----
 
 
 
 
ReceivablesReceivables0.000.00------
 
InventoriesInventories0.000.00------
 
Current AssetsPrepaid Expenses4.2M7.1M----
 
 
 
Other Current Assets889.0K2.1M----
 
 
 
Current Assets97.1M445.2M----
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross467.0K1.8M----
 
 
 
Depreciation-27.0K-231.0K----
 
 
 
Other Assets92.0K934.0K----
 
 
 
Total Assets98.0M464.9M----
 
 
 
 
LiabilitiesAccounts Payable1.9M13.5M----
 
 
 
Accrued Expenses4.2M11.0M----
 
 
 
Other Current Liabilities4.2M14.0M----
 
 
 
Other Liabilities8.6M32.6M----
 
 
 
 
Total LiabilitiesLong Term Debt143.9M533.4M----
 
 
 
Other Liabilities312.0K495.0K----
 
 
 
Total Liabilities152.7M566.4M----
 
 
 
 
EquityMinority Interest-13.3M-38.7M----
 
 
 
Preferred Stock3.4M6.6M----
 
 
 
Common Equity-61.4M-170.6M----
 
 
 
Total Shareholder Equity-58.0M-164.0M----
 
 
 
 
Share InformationCommon Shares Outstanding117.2M123.0M----
 
 
 
 
Addtl. Info.No data currently available for this section.